CCL5, while being minimally expressed by normal breast epithelial duct cells, is highly expressed by breast tumor cells at primary tumor sites, regional lymph nodes, and metastatic sites, indicating that CCL5 expression is acquired in the course of malignant transformation [18] and that CCL5 plays a role in breast cancer development and/or progression. The gene discussed is CCL5; the disease is breast neoplasm.